Previous Article | Next Article 
Molecular and Cellular Biology, December 2001, p. 8056-8067, Vol. 21, No. 23
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.23.8056-8067.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Cdc25B Functions as a Novel Coactivator for the Steroid
Receptors
Zhi-Qing
Ma,
Zheng
Liu,
Elly S. W.
Ngan, and
Sophia Y.
Tsai*
Department of Molecular and Cellular Biology,
Baylor College of Medicine, Houston, Texas 77030
Received 5 July 2001/Returned for modification 4 August
2001/Accepted 4 September 2001
We have previously demonstrated that overexpression of
Cdc25B in transgenic mice resulted in mammary gland hyperplasia and increased steroid hormone responsiveness. To address how Cdc25B enhances the hormone responsiveness in mammary glands, we showed that
Cdc25B stimulates steroid receptor-dependent transcription in transient
transfection assays and in a cell-free assay with chromatin templates.
Surprisingly, the effect of Cdc25B on steroid receptors is independent
of its protein phosphatase activity in vitro. The direct interactions
of Cdc25B with steroid receptors, on the other hand, were evidenced in
in vivo and in vitro assays, suggesting the potential direct
contribution of Cdc25B on the steroid receptor-mediated transcription.
In addition, p300/CBP-associated factor and CREB binding protein were
shown to interact and synergize with Cdc25B and further enhance its
coactivation activity. Thus, we have uncovered a novel function of
Cdc25B that serves as a steroid receptor coactivator in addition to its
role as a regulator for cell cycle progression. This dual function
might likely contribute to its oncogenic action in breast cancer.
*
Corresponding author. Mailing address: Department of
Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Phone: (713) 798-6251. Fax: (713) 798-8227. E-mail: stsai{at}bcm.tmc.edu.
Molecular and Cellular Biology, December 2001, p. 8056-8067, Vol. 21, No. 23
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.23.8056-8067.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Heemers, H. V., Tindall, D. J.
(2007). Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex. Endocr. Rev.
28: 778-808
[Abstract]
[Full Text]
-
Srivastava, S. K., Bansal, P., Oguri, T., Lazo, J. S., Singh, S. V.
(2007). Cell Division Cycle 25B Phosphatase Is Essential for Benzo(a)Pyrene-7,8-Diol-9,10-Epoxide Induced Neoplastic Transformation. Cancer Res.
67: 9150-9157
[Abstract]
[Full Text]
-
Proia, D. A., Nannenga, B. W., Donehower, L. A., Weigel, N. L.
(2006). Dual Roles for the Phosphatase PPM1D in Regulating Progesterone Receptor Function. J. Biol. Chem.
281: 7089-7101
[Abstract]
[Full Text]
-
Kasper, L. H., Fukuyama, T., Biesen, M. A., Boussouar, F., Tong, C., de Pauw, A., Murray, P. J., van Deursen, J. M. A., Brindle, P. K.
(2006). Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development. Mol. Cell. Biol.
26: 789-809
[Abstract]
[Full Text]
-
Brezak, M.-C., Quaranta, M., Contour-Galcera, M.-O., Lavergne, O., Mondesert, O., Auvray, P., Kasprzyk, P. G., Prevost, G. P., Ducommun, B.
(2005). Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases. Molecular Cancer Therapeutics
4: 1378-1387
[Abstract]
[Full Text]
-
Martin, P. J., Lardeux, V., Lefebvre, P.
(2005). The proliferating cell nuclear antigen regulates retinoic acid receptor transcriptional activity through direct protein-protein interaction. Nucleic Acids Res
33: 4311-4321
[Abstract]
[Full Text]
-
Lindqvist, A., Kallstrom, H., Karlsson Rosenthal, C.
(2004). Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress. J. Cell Sci.
117: 4979-4990
[Abstract]
[Full Text]
-
Smith, C. L., O'Malley, B. W.
(2004). Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators. Endocr. Rev.
25: 45-71
[Abstract]
[Full Text]
-
Wu, W., Slomovitz, B. M., Celestino, J., Chung, L., Thornton, A., Lu, K. H.
(2003). Coordinate Expression of Cdc25B and ER-{alpha} Is Frequent in Low-Grade Endometrioid Endometrial Carcinoma but Uncommon in High-Grade Endometrioid and Nonendometrioid Carcinomas. Cancer Res.
63: 6195-6199
[Abstract]
[Full Text]
-
Ducruet, A. P., Lazo, J. S.
(2003). Regulation of Cdc25A Half-life in Interphase by Cyclin-dependent Kinase 2 Activity. J. Biol. Chem.
278: 31838-31842
[Abstract]
[Full Text]
-
Kasai, M., Guerrero-Santoro, J., Friedman, R., Leman, E. S., Getzenberg, R. H., DeFranco, D. B.
(2003). The Group 3 LIM Domain Protein Paxillin Potentiates Androgen Receptor Transactivation in Prostate Cancer Cell Lines. Cancer Res.
63: 4927-4935
[Abstract]
[Full Text]
-
Lazo, J. S., Ducruet, A. P., Koldamova, R. P.
(2003). Sleuthful Pharmacology. Mol. Pharmacol.
64: 199-201
[Full Text]
-
Oguri, T., Singh, S. V., Nemoto, K., Lazo, J. S.
(2003). The Carcinogen (7R,8S)-Dihydroxy-(9S,10R)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene Induces Cdc25B Expression in Human Bronchial and Lung Cancer Cells. Cancer Res.
63: 771-775
[Abstract]
[Full Text]